Year |
Citation |
Score |
2024 |
Lemieux A, Sannier G, Nicolas A, Nayrac M, Delgado GG, Cloutier R, Brassard N, Laporte M, Duchesne M, Sreng Flores AM, Finzi A, Tastet O, Dubé M, Kaufmann DE. Enhanced detection of antigen-specific T cells by a multiplexed AIM assay. Cell Reports Methods. 100690. PMID 38228152 DOI: 10.1016/j.crmeth.2023.100690 |
0.36 |
|
2023 |
Dubé M, Tastet O, Dufour C, Sannier G, Brassard N, Delgado GG, Pagliuzza A, Richard C, Nayrac M, Routy JP, Prat A, Estes JD, Fromentin R, Chomont N, Kaufmann DE. Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4 and CD8 T cells. Cell Host & Microbe. 31: 1507-1522.e5. PMID 37708853 DOI: 10.1016/j.chom.2023.08.006 |
0.457 |
|
2023 |
Richard J, Prévost J, Bourassa C, Brassard N, Boutin M, Benlarbi M, Goyette G, Medjahed H, Gendron-Lepage G, Gaudette F, Chen HC, Tolbert WD, Smith AB, Pazgier M, Dubé M, et al. Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120. Cell Chemical Biology. PMID 36958337 DOI: 10.1016/j.chembiol.2023.03.003 |
0.545 |
|
2023 |
Sannier G, Nicolas A, Dubé M, Marchitto L, Nayrac M, Tastet O, Chatterjee D, Tauzin A, Lima-Barbosa R, Laporte M, Cloutier R, Sreng Flores AM, Boutin M, Gong SY, Benlarbi M, et al. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4 T cell profile. Cell Reports. Medicine. 100955. PMID 36863335 DOI: 10.1016/j.xcrm.2023.100955 |
0.385 |
|
2022 |
Nicolas A, Sannier G, Dubé M, Nayrac M, Tauzin A, Painter MM, Goel RR, Laporte M, Gendron-Lepage G, Medjahed H, Williams JC, Brassard N, Niessl J, Gokool L, Morrisseau C, et al. Extended SARS-CoV-2 mRNA vaccine prime-boost intervals enhances B cell immunity with limited impact on T cells. Iscience. 105904. PMID 36594081 DOI: 10.1016/j.isci.2022.105904 |
0.356 |
|
2022 |
Brunet-Ratnasingham E, Morou A, Dubé M, Niessl J, Baxter AE, Tastet O, Brassard N, Ortega-Delgado G, Charlebois R, Freeman GJ, Tremblay C, Routy JP, Kaufmann DE. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function. Ebiomedicine. 84: 104254. PMID 36150362 DOI: 10.1016/j.ebiom.2022.104254 |
0.44 |
|
2022 |
Wietgrefe SW, Duan L, Anderson J, Marqués G, Sanders M, Cummins NW, Badley AD, Dobrowolski C, Karn J, Pagliuzza A, Chomont N, Sannier G, Dubé M, Kaufmann DE, Zuck P, et al. Detecting Sources of Immune Activation and Viral Rebound in HIV Infection. Journal of Virology. e0088522. PMID 35856674 DOI: 10.1128/jvi.00885-22 |
0.397 |
|
2022 |
Nayrac M, Dubé M, Sannier G, Nicolas A, Marchitto L, Tastet O, Tauzin A, Brassard N, Lima-Barbosa R, Beaudoin-Bussières G, Vézina D, Gong SY, Benlarbi M, Gasser R, Laumaea A, et al. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen. Cell Reports. 39: 111013. PMID 35732172 DOI: 10.1016/j.celrep.2022.111013 |
0.537 |
|
2022 |
Dubé M, Kaufmann DE. Single-Cell Multiparametric Analysis of Rare HIV-Infected Cells Identified by Duplexed RNAflow-FISH. Methods in Molecular Biology (Clifton, N.J.). 2407: 291-313. PMID 34985672 DOI: 10.1007/978-1-0716-1871-4_20 |
0.401 |
|
2021 |
Nayrac M, Dubé M, Sannier G, Nicolas A, Marchitto L, Tastet O, Tauzin A, Brassard N, Beaudoin-Bussières G, Vézina D, Gong SY, Benlarbi M, Gasser R, Laumaea A, Bourassa C, et al. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen. Biorxiv : the Preprint Server For Biology. PMID 34981046 DOI: 10.1101/2021.12.18.473317 |
0.532 |
|
2021 |
Tauzin A, Gong SY, Beaudoin-Bussières G, Vézina D, Gasser R, Nault L, Marchitto L, Benlarbi M, Chatterjee D, Nayrac M, Laumaea A, Prévost J, Boutin M, Sannier G, Nicolas A, et al. Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses. Cell Host & Microbe. PMID 34953513 DOI: 10.1016/j.chom.2021.12.004 |
0.445 |
|
2021 |
Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, Beaudoin-Bussières G, Pagliuzza A, Gasser R, Benlarbi M, Point F, Prévost J, Laumaea A, Niessl J, Nayrac M, et al. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Science Advances. 7: eabj5629. PMID 34826237 DOI: 10.1126/sciadv.abj5629 |
0.361 |
|
2021 |
Sannier G, Dubé M, Dufour C, Richard C, Brassard N, Delgado GG, Pagliuzza A, Baxter AE, Niessl J, Brunet-Ratnasingham E, Charlebois R, Routy B, Routy JP, Fromentin R, Chomont N, et al. Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity. Cell Reports. 36: 109643. PMID 34469719 DOI: 10.1016/j.celrep.2021.109643 |
0.355 |
|
2020 |
Niessl J, Baxter AE, Morou A, Brunet-Ratnasingham E, Sannier G, Gendron-Lepage G, Richard J, Delgado GG, Brassard N, Turcotte I, Fromentin R, Bernard NF, Chomont N, Routy JP, Dubé M, et al. Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy. Ebiomedicine. 54: 102727. PMID 32268275 DOI: 10.1016/J.Ebiom.2020.102727 |
0.613 |
|
2020 |
Sannier G, Dubé M, Kaufmann DE. Single-Cell Technologies Applied to HIV-1 Research: Reaching Maturity. Frontiers in Microbiology. 11: 297. PMID 32194526 DOI: 10.3389/Fmicb.2020.00297 |
0.427 |
|
2020 |
Niessl J, Baxter AE, Mendoza P, Jankovic M, Cohen YZ, Butler AL, Lu CL, Dubé M, Shimeliovich I, Gruell H, Klein F, Caskey M, Nussenzweig MC, Kaufmann DE. Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity. Nature Medicine. PMID 32015556 DOI: 10.1038/S41591-019-0747-1 |
0.546 |
|
2020 |
Prévost J, Edgar CR, Richard J, Trothen SM, Jacob RA, Mumby MJ, Pickering S, Dubé M, Kaufmann DE, Kirchhoff F, Neil SJD, Finzi A, Dikeakos JD. HIV-1 Vpu downregulates Tim-3 from the surface of infected CD4 T cells. Journal of Virology. PMID 31941771 DOI: 10.1128/Jvi.01999-19 |
0.619 |
|
2019 |
Morou A, Brunet-Ratnasingham E, Dubé M, Charlebois R, Mercier E, Darko S, Brassard N, Nganou-Makamdop K, Arumugam S, Gendron-Lepage G, Yang L, Niessl J, Baxter AE, Billingsley JM, Rajakumar PA, et al. Altered differentiation is central to HIV-specific CD4 T cell dysfunction in progressive disease. Nature Immunology. PMID 31308541 DOI: 10.1038/S41590-019-0418-X |
0.513 |
|
2019 |
Prévost J, Pickering S, Mumby MJ, Medjahed H, Gendron-Lepage G, Delgado GG, Dirk BS, Dikeakos JD, Stürzel CM, Sauter D, Kirchhoff F, Bibollet-Ruche F, Hahn BH, Dubé M, Kaufmann DE, et al. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses. Mbio. 10. PMID 31213558 DOI: 10.1128/Mbio.01113-19 |
0.588 |
|
2019 |
Brunet-Ratnasingham E, Dubé M, Kaufmann DE. Targeting Mitochondria to Revive Dysfunctional Regulatory T Cells. Trends in Molecular Medicine. 25: 1-3. PMID 30473188 DOI: 10.1016/J.Molmed.2018.11.001 |
0.471 |
|
2018 |
Porichis F, Hart MG, Massa A, Everett HL, Morou A, Richard J, Brassard N, Veillette M, Hassan M, Ly NL, Routy JP, Freeman GJ, Dubé M, Finzi A, Kaufmann DE. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 29934472 DOI: 10.4049/Jimmunol.1701551 |
0.622 |
|
2013 |
Dube MW. HIV+ feminisms, postcoloniality and the global AIDS crisis Another World Is Possible: Spiritualities and Religions of Global Darker Peoples. 145-159. |
0.307 |
|
2012 |
Dube MW. Mainstreaming HIV/AIDS in African religious and theological studies African Traditions in the Study of Religion in Africa: Emerging Trends, Indigenous Spirituality and the Interface With Other World Religions. 77-92. |
0.308 |
|
Show low-probability matches. |